These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9846283)

  • 1. [Antimicrobial activity of ofloxacin against recent clinical isolates from otitis media and otitis externa].
    Matsumoto Y; Suzuki Y; Ishii Y; Ishihara R; Nakazawa A; Nakane Y; Nishinari C; Deguchi K
    Jpn J Antibiot; 1998 Sep; 51(9):561-75. PubMed ID: 9846283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial activities of fosfomycin against recent clinical isolates from patients of otitis media and otitis externa].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1995 Feb; 48(2):293-8. PubMed ID: 7745818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacterial activities of ofloxacin against recent isolates from patients with community-acquired infections].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1991 Sep; 44(9):941-57. PubMed ID: 1960856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activities of cefmenoxime against recent clinical isolates from patients of otitis media and otitis externa].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Oct; 46(10):850-9. PubMed ID: 8254887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacteriological evaluation of ofloxacin otic solution].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1342-55. PubMed ID: 1479686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibilities of Escherichia coli, Salmonella and Staphylococcus aureus isolated from animals to ofloxacin and commonly used antimicrobial agents].
    Takahashi I; Yoshida T; Higashide Y; Sakano T
    Jpn J Antibiot; 1990 Jan; 43(1):89-99. PubMed ID: 2190017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial activities of norfloxacin against clinical isolates from ocular infections].
    Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Aug; 48(8):1009-25. PubMed ID: 7474324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.
    Klein JO
    Pediatr Infect Dis J; 2001 Jan; 20(1):102-3; discussion 120-2. PubMed ID: 11176586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methicillin-resistant staphylococci and ofloxacin-resistant bacteria from clinically healthy conjunctivas.
    Watanabe K; Numata-Watanabe K; Hayasaka S
    Ophthalmic Res; 2001; 33(3):136-9. PubMed ID: 11340403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of clinical bacteriological efficacy in a cefmenoxime ototopical solution].
    Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
    Jpn J Antibiot; 1985 Jul; 38(7):1739-49. PubMed ID: 3906166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kawaguchi H; Shimizu Y; Matsumiya H; Saito A; Terai T; Inoue H; Nakadate T; Ito C; Yosida T; Tanno Y; Ohno I; Nishioka K; Arakawa M; Igarashi K; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Touyama M
    Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial activities of cefuroxime against recent clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1994 Apr; 47(4):365-82. PubMed ID: 8201767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation-frequency and antibiotic susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa isolated in regional core hospitals in the Nagaoka district of Niigata Prefecture (changes for 3 years)].
    Iwashima A; Sato K; Kiguchi T; Yamaguchi M
    Jpn J Antibiot; 2004 Feb; 57(1):105-17. PubMed ID: 15116575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibilities of clinical isolates to antibacterial agents. A study mainly focused on ofloxacin (the second report). Reported by the Research Group for Testing ofloxacin Susceptibility on Clinical Isolates].
    Kosakai N
    Jpn J Antibiot; 1989 May; 42(5):1125-65. PubMed ID: 2664255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and antibiotic susceptibility of bacterial isolates from dogs with otitis externa in Australia.
    Bugden DL
    Aust Vet J; 2013; 91(1-2):43-6. PubMed ID: 23356371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.